An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A Reddit user asked why dosing recommendations for a peptide called SS-31 are all over the place. They reported seeing numbers from 200 micrograms (mcg) a day up to 90 milligrams (mg) a day on different sites and asked if anyone has a reliable source for how much to take and how to cycle it. The post is basically someone confused by wildly different numbers on forums, wikis, and vendor pages and looking for a clear answer. SS-31 (also called elamipretide in clinical research) is a small peptide designed to target mitochondria — the energy factories inside cells. In plain terms, it’s a lab-made short protein that’s supposed to protect and improve the function of mitochondria. That’s why researchers have studied it for conditions where cells’ energy production is faulty, like certain rare genetic diseases, heart problems, and aging models. It’s not the same as popular weight-loss drugs like Ozempic; it’s a different class of molecule with different intended uses. What matters here is the evidence. Most of the reliable dosing information for SS-31 comes from controlled clinical trials or animal studies, not from user forums. In human trials where elamipretide was tested, doses were given under medical supervision, often as injections or IV, and the amounts, schedules, and goals varied by study. Forum posts and vendor pages often list “experimental” or anecdotal doses that aren’t based on approved prescribing guidance. That’s why you see tiny numbers like 200 mcg next to huge numbers like 90 mg — different units, different contexts (animal vs. human), or plain mistakes. The real, clinically studied doses are narrower and come from published papers and trial protocols, but they’re not the same as an over-the-counter, do-it-yourself regimen. Why this matters for a regular person: if you’re considering any peptide because you’ve read a headline or a recommendation online, dosing confusion is dangerous. Using the wrong dose could be ineffective at best and risky at worst. People who might care include patients with specific mitochondrial disorders (under a doctor’s care), researchers, and biohackers curious about cellular aging. For everyone else, the practical takeaway is to rely on peer-reviewed studies or clinical trial data, and to involve a qualified clinician for interpretation. Forum anecdotes don’t replace medical guidance. Caveats and risks: SS-31/elamipretide is an investigational compound in many settings. Side effects reported in trials include injection-site reactions and other manageable issues, but long-term safety and appropriate dosing for off-label uses are not established. Internet vendors and wikis can mix up micrograms and milligrams or misapply animal-study doses to humans. Don’t self-dose based on a Reddit thread. If you think you have a condition that might benefit from a mitochondrial therapy, talk to a physician or look up registered clinical trials and published papers for accurate dosing and safety data. Bottom line: the wild range you see online reflects mixed sources, unit confusion, and anecdote — use clinical trial reports and a medical professional, not forum dosage lists.
Source: r/Peptides